The Use of Campath-1H as Induction Therapy in Renal Transplantation: Preliminary Results-Reference-Cited by-同舟云学术

The Use of Campath-1H as Induction Therapy in Renal Transplantation: Preliminary Results

Published:2004-08 Issue:3 Volume:78 Page:426-433
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Ciancio Gaetano,Burke George W.,Gaynor Jeffrey J.,Mattiazzi Adela,Roohipour Ramin,Carreno Manuel R.,Roth David,Ruiz Phillip,Kupin Warren,Rosen Anne,Esquenazi Violet,Tzakis Andreas G.,Miller Joshua

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference31 articles.

1. A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1

2. A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

3. MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANTATION: 3-YEAR RESULTS FROM THE PLACEBO-CONTROLLED TRIAL1

4. A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTS

5. MYCOPHENOLATE MOFETIL REDUCES LATE RENAL ALLOGRAFT LOSS INDEPENDENT OF ACUTE REJECTION

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steroid‐free maintenance immunosuppression using alemtuzumab in pediatric kidney transplantation: Long‐term longitudinal follow‐up;Pediatric Transplantation;2021-10-23

2. Mineral and Bone Disorders Following Renal Transplantation;Endocrine Disorders in Kidney Disease;2019

3. Immunosuppression: Have We Learnt Anything?;Seminars in Respiratory and Critical Care Medicine;2018-03-26

4. Induction and Standard Immunosuppression;Solid Organ Transplantation in Infants and Children;2018

5. Weight-based dosing of alemtuzumab: an ounce of prevention?;Transplant International;2017-10-16